ITUA20161418A1 - Biomarcatori urinari per la diagnosi del carcinoma della prostata - Google Patents

Biomarcatori urinari per la diagnosi del carcinoma della prostata

Info

Publication number
ITUA20161418A1
ITUA20161418A1 ITUA2016A001418A ITUA20161418A ITUA20161418A1 IT UA20161418 A1 ITUA20161418 A1 IT UA20161418A1 IT UA2016A001418 A ITUA2016A001418 A IT UA2016A001418A IT UA20161418 A ITUA20161418 A IT UA20161418A IT UA20161418 A1 ITUA20161418 A1 IT UA20161418A1
Authority
IT
Italy
Prior art keywords
biomarcers
urinary
diagnosis
prostate carcinoma
carcinoma
Prior art date
Application number
ITUA2016A001418A
Other languages
English (en)
Inventor
Mirella Giovarelli
Sergio Occhipinti
Original Assignee
Univ Degli Studi Di Torino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Torino filed Critical Univ Degli Studi Di Torino
Priority to ITUA2016A001418A priority Critical patent/ITUA20161418A1/it
Priority to PCT/IB2017/051177 priority patent/WO2017153869A1/en
Publication of ITUA20161418A1 publication Critical patent/ITUA20161418A1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/49—Platelet-derived growth factor [PDGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/521—Chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/53—Colony-stimulating factor [CSF]
    • G01N2333/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5412—IL-6
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5421—IL-8

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ITUA2016A001418A 2016-03-07 2016-03-07 Biomarcatori urinari per la diagnosi del carcinoma della prostata ITUA20161418A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITUA2016A001418A ITUA20161418A1 (it) 2016-03-07 2016-03-07 Biomarcatori urinari per la diagnosi del carcinoma della prostata
PCT/IB2017/051177 WO2017153869A1 (en) 2016-03-07 2017-02-28 Method for in vitro diagnosis of prostate cancer by means of urinary biomarkers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A001418A ITUA20161418A1 (it) 2016-03-07 2016-03-07 Biomarcatori urinari per la diagnosi del carcinoma della prostata

Publications (1)

Publication Number Publication Date
ITUA20161418A1 true ITUA20161418A1 (it) 2017-09-07

Family

ID=56203544

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A001418A ITUA20161418A1 (it) 2016-03-07 2016-03-07 Biomarcatori urinari per la diagnosi del carcinoma della prostata

Country Status (2)

Country Link
IT (1) ITUA20161418A1 (it)
WO (1) WO2017153869A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019352906A1 (en) * 2018-10-05 2021-06-10 Minomic International Ltd. Biomarker combinations for determining aggressive prostate cancer
IT202000029948A1 (it) * 2020-12-04 2022-06-04 Nib Biotec S R L Metodo per la diagnosi di tumore alla prostata in pazienti in differente fascia di età

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
WO2011016031A2 (en) * 2009-08-03 2011-02-10 Yeda Research And Development Co. Ltd. Urinary biomarkers for cancer diagnosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
WO2011016031A2 (en) * 2009-08-03 2011-02-10 Yeda Research And Development Co. Ltd. Urinary biomarkers for cancer diagnosis

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ALISA J PRAGER ET AL: "Urinary a HGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer", BIOMARKERS IN MEDICINE, vol. 7, no. 6, 1 December 2013 (2013-12-01), UK, pages 831 - 841, XP055315374, ISSN: 1752-0363, DOI: 10.2217/bmm.13.112 *
ANONYMOUS: "RayBio Human Cytokine Antibody Array G-Series 5", RAYBIO, 1 January 2012 (2012-01-01), pages 1 - 28, XP055315953, Retrieved from the Internet <URL:https://www.biocat.com/bc/pdf/AAH-CYT-G5_090913.pdf> [retrieved on 20161102] *
CHRISTOPH ADERHOLD ET AL: "Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study", ONCOLOGY LETTERS, 4 July 2014 (2014-07-04), GR, XP055315863, ISSN: 1792-1074, DOI: 10.3892/ol.2014.2312 *
DESPOINA TRAMMA ET AL: "Interleukin-6 and interleukin-8 levels in the urine of children with renal scarring", PEDIATRIC NEPHROLOGY., vol. 27, no. 9, 24 April 2012 (2012-04-24), DE, pages 1525 - 1530, XP055315846, ISSN: 0931-041X, DOI: 10.1007/s00467-012-2156-2 *
ELIO DEFILIPPI ET AL: "Alternative tests to PSA for prostate cancer diagnosis", UROLOGIA : RIVISTA INTERNAZIONALE DI CULTURA UROLOGICA ; ORGANO UFFICIALE, vol. 78, no. 2, 1 January 2011 (2011-01-01), Italy, pages 75 - 81, XP055315382, ISSN: 0391-5603, DOI: 10.5301/RU.2011.7973 *
MARINA RIGAU ET AL: "The Present and Future of Prostate Cancer Urine Biomarkers", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 14, no. 6, 17 June 2013 (2013-06-17), pages 12620 - 12649, XP055315484, DOI: 10.3390/ijms140612620 *
SRINIVAS PENTYALA ET AL: "Prostate cancer markers: An update (Review)", BIOMEDICAL REPORTS MAY 2014 SPANDIDOS PUBLICATIONS GBR, 29 January 2016 (2016-01-29), Greece, XP055315545, ISSN: 2049-9434, DOI: 10.3892/br.2016.586 *
STUART E LIND ET AL: "Correlates of thrombin generation in patients with advanced prostate cancer", THROMBOSIS AND HAEMOSTASIS, SCHATTAUER GMBH, DE, vol. 89, no. 1, 1 January 2003 (2003-01-01), pages 185 - 189, XP008132572, ISSN: 0340-6245 *

Also Published As

Publication number Publication date
WO2017153869A1 (en) 2017-09-14

Similar Documents

Publication Publication Date Title
DK3506854T3 (da) Brystbehandlingsindretning
DK3240801T3 (da) Kombinationstumorimmunterapi
DK3212670T3 (da) Kombinationsterapi mod cancer
DK3033086T3 (da) Kombinationsterapi til behandling af cancer
DK3474841T3 (da) Fremgangsmåder til behandling af ar+-brystkræft
DK3194000T3 (da) Krumt urinkateter
MA41449A (fr) Polythérapies pour le traitement de cancers
ECSP17015977A (es) Terapia de combinacion
KR20180084772A (ko) 암 치료를 위한 조합 치료법
MA43000A (fr) Polythérapie pour le traitement de tumeurs malignes
MA46361A (fr) Traitement du cancer de la prostate
MA45780A (fr) Méthodes de traitement du cancer de la prostate
DK3123381T3 (da) Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer
MA47408A (fr) Traitement du cancer
MA48728A (fr) Polythérapie contre le cancer de la prostate
DK3374497T3 (da) Modificerede makrofager til anvendelse i behandlingen af kræft
KR102377742B1 (ko) 암치료약
DK3290079T3 (da) Kateterrør
DK3253208T3 (da) Kombinationsterapier til anvendelse i behandlingen af brystcancer
DK3408265T3 (da) Terapeutiske forbindelser
IT201600121617A1 (it) Composizione per il trattamento del reflusso gastroesofageo
DK3576740T3 (da) Cancerbehandling
DK3580182T3 (da) Vandbehandling
DK3407909T3 (da) Cancerbehandling
ITUA20161418A1 (it) Biomarcatori urinari per la diagnosi del carcinoma della prostata